Tonix Pharmaceuticals Holding (TNXP) Change in Cash (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Change in Cash of -$23.8 million for Q1 2026, down 172.25% year-over-year from $32.9 million in Q1 2025, and down 228.94% quarter-over-quarter from $18.5 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Change in Cash (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Change in Cash history runs 17 years deep, the most recent figure standing at -$23.8 million for Q1 2026.
- In Q1 2026, Change in Cash fell 172.25% year-over-year to -$23.8 million; the TTM figure through Mar 2026 stood at $53.4 million (down 57.18% YoY), while the FY2025 annual figure was $110.1 million, up 49.16% from the prior year.
- Change in Cash for Q1 2026 stood at -$23.8 million, down from $18.5 million in the prior quarter.
- The five-year high for Change in Cash was $70.5 million in Q4 2024, with the low at -$48.3 million in Q1 2023.
- The 5-year median for Change in Cash is -$6.4 million (2025), against an average of $418117.6.
- Peak annual rise in Change in Cash reached 2328.11% in 2022, while the deepest fall reached 358.19% in 2022.
- Tonix Pharmaceuticals Holding's Change in Cash stood at -$19.7 million in 2022, then jumped by 190.81% to $17.9 million in 2023, then soared by 293.38% to $70.5 million in 2024, then sank by 73.84% to $18.5 million in 2025, then tumbled by 228.94% to -$23.8 million in 2026.
- Business Quant data shows TNXP's Change in Cash at -$23.8 million in Q1 2026, $18.5 million in Q4 2025, and $65.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -9.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.39 Mn |
| Mar 31, 2026 | -23.80 Mn |
| Dec 31, 2025 | 18.46 Mn |
| Sep 30, 2025 | 65.11 Mn |
| Jun 30, 2025 | -6.38 Mn |
| Mar 31, 2025 | 32.94 Mn |
| Dec 31, 2024 | 70.55 Mn |
| Sep 30, 2024 | 24.08 Mn |
| Jun 30, 2024 | -2.89 Mn |
| Mar 31, 2024 | -17.90 Mn |
| Dec 31, 2023 | 17.93 Mn |
| Sep 30, 2023 | -17.94 Mn |
| Jun 30, 2023 | -46.36 Mn |
| Mar 31, 2023 | -48.25 Mn |
| Dec 31, 2022 | -19.75 Mn |
| Sep 30, 2022 | -37.00 Mn |
| Jun 30, 2022 | 36.54 Mn |
| Mar 31, 2022 | -38.23 Mn |
| Dec 31, 2021 | -4.31 Mn |
| Sep 30, 2021 | 17.25 Mn |